Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of Epuris®
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba
Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa
Alvopetro Announces June Sales Volumes, an Operational Update and Quarterly Natural Gas Pricing Update
